Hepatic Metabolism and Elimination

The liver is the principal site of drug metabolism, chemically transforming drugs into metabolites that are usually more water-soluble and more readily excreted. Hepatic metabolism, together with biliary excretion, accounts for the elimination of many drugs, and the rate at which the liver clears a drug depends on hepatic blood flow, enzyme activity, and protein binding.

Definition

Hepatic metabolism is the enzymatic biotransformation of drugs, conventionally divided into phase I (functionalization) and phase II (conjugation) reactions; hepatic clearance is the volume of blood cleared of drug per unit time by the liver, determined by hepatic blood flow, the unbound fraction, and intrinsic metabolic capacity.

Scope

This topic covers the phases of drug biotransformation, the cytochrome P450 system, the determinants of hepatic clearance, the extraction ratio, and the physiological models that describe how the liver removes drugs from blood. It is a reference and educational entry and does not give dosing or interaction-management advice.

Core questions

• How does the liver chemically transform drugs into excretable forms?
• Which enzyme systems carry out drug biotransformation?
• What determines how rapidly the liver clears a given drug?
• How do flow-limited and capacity-limited drugs differ in their clearance behaviour?

Key concepts

• Phase I and phase II biotransformation
• Cytochrome P450 enzymes
• Hepatic extraction ratio
• Intrinsic clearance
• Flow-limited versus capacity-limited elimination
• First-pass metabolism
• Biliary excretion and enterohepatic recirculation

Key theories

Well-stirred (venous equilibrium) model of hepatic clearance

Wilkinson and Shand expressed hepatic clearance as a function of hepatic blood flow, the unbound fraction, and intrinsic clearance, distinguishing flow-limited (high-extraction) from capacity-limited (low-extraction) drugs.

Dispersion model of hepatic elimination

Roberts and Rowland described hepatic elimination using a dispersion model that represents the distribution of blood transit times through the liver, offering an alternative to the well-stirred and parallel-tube models.

Mechanisms

Drugs are metabolized chiefly by phase I reactions (oxidation, reduction, hydrolysis), often catalyzed by cytochrome P450 enzymes, and phase II conjugation reactions that attach polar groups to enhance excretion. The resulting metabolites are eliminated in bile or urine. Hepatic clearance is governed by hepatic blood flow, the unbound fraction of drug, and the intrinsic clearance of the metabolizing enzymes; for high-extraction drugs clearance approaches blood flow and is flow-limited, whereas for low-extraction drugs it depends on enzyme activity and binding and is capacity-limited. Physiological clearance models, including the well-stirred and dispersion formulations, relate these determinants to the fraction of drug removed in a single pass through the liver.

Clinical relevance

Hepatic metabolism underlies the first-pass effect, much of the variability in drug exposure, and the basis for many drug-drug interactions and pharmacogenetic differences. This entry summarizes these mechanisms for educational reference and is not a source of advice on dosing or managing interactions.

Evidence & guidelines

Regulatory agencies publish technical guidance on evaluating drug metabolism and metabolism-based drug interactions; the underlying clearance theory is presented in standard pharmacokinetics texts.

History

The physiological understanding of hepatic clearance was consolidated in the 1970s when Wilkinson and Shand expressed clearance in terms of blood flow, binding, and intrinsic activity, distinguishing flow- from capacity-limited drugs. Subsequent work, including the dispersion model of Roberts and Rowland, refined how the liver's internal transport is represented, while the molecular characterization of the cytochrome P450 enzymes explained much of the variability in metabolism.

Debates

Which physiological model best describes hepatic clearance?

The well-stirred, parallel-tube, and dispersion models make different assumptions about how drug concentration varies along the hepatic sinusoids, and they can diverge for high-extraction drugs; the choice of model remains a methodological discussion in pharmacokinetics.

Key figures

• Grant Wilkinson
• Donald Shand
• Malcolm Rowland
• Michael Roberts

Seminal works

• wilkinson-shand-1975
• roberts-rowland-1986

Frequently asked questions

What is the difference between phase I and phase II metabolism?

Phase I reactions introduce or expose a functional group (for example by oxidation), often via cytochrome P450 enzymes, while phase II reactions conjugate the drug or metabolite with a polar molecule to make it more water-soluble for excretion.

What is a high-extraction drug?

A high-extraction drug is one the liver removes very efficiently in a single pass, so its hepatic clearance approaches hepatic blood flow and is sensitive to changes in flow rather than to enzyme activity.